Back to Journals » Therapeutics and Clinical Risk Management » Volume 10
Review
Emerging treatments in type 2 diabetes: focus on canagliflozin
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
11,663 | Dovepress* | 9,509+ | 2,460 | 11,969 | |
PubMed Central* | 2,154 | 968 | 3,122 | ||
Totals | 11,663 | 3,428 | 15,091 | ||
*Since 21 August 2014 +Since July 2016 |
View citations on PubMed Central and Google Scholar